The effect of antibiotherapy used against the PSA increase in serum PSA levels

Year 2015, Volume: 20 Issue: 1, 30 - 33, 02.06.2015

Ayhan Karaköse , Mehmet Yüksel , Necip Pirinççi , Sacit Görgel Yusuf Ateşçi Bilal Gümüş

Abstract

Aim.To evaluatethe effect of antibiotics in patients with PSA value high than 4 ng / ml ontPSA, fPSA and fPSA / tPSA ratio.Methods.A total of96 patients  included the study withdetected high level than 4 ng / ml serum PSA. Patients were divided into 2groups according to the high level of PSA value. Group 1 included 49 patients with PSA level between 4-10ng/ml. Group 2 included 47 patients with PSA level high than 10 ng/ml. Patientswere treated with  Ciprofloxacin (500mgb.i.d.) orally for 2 weeks. All patients' PSA levels  were evaluated and analyzed before and afterantibiotic treatment. Statistical analyses were performed with SPSS version 18.A p value <0.05 was considered significant.Results.The meanage was 61.6 ±5.7 (51-75) years in group 1 and 63.1 ±8.7 (55-74) years in group2. Suspicious DRE findings were significantly high  in group 2. The mean tPSA values were6.82±0.42 and 5.93±0.36 before and after antibiotic treatment in group 1respectively. There was no significant differences tPSA value before and afterantibiotic treatment in group 1.  Themean tPSA values were 32.53±8.23 and 11.72±5.61 before and after antibiotictreatment in group 2 respectively. The mean tPSA value decreased significantlyafter antibiotic treatment in group 2. Prostate cancer was detected in 32 patients after TRUS guided prostatebiopsy.  Prostate cancer was identifiedin 13 patients in gruop 1 and 19 patients in group 2. Conclusıons.Antibiotic treatment in patients with PSA levels high than 10 ng/ml iseffective on prostate biopsy decision and antibiotic treatment can preventunnecessary prostate biopsies.

Keywords

Prostate, cancer, PSA, biopsy

References

• Bulbul MA, Wassan W, Hijaz A, et al. The effect of
• antibiotics on elevated serum prostate-specific antigen
• in patients with urinary symptoms and negative digital
• rectal examination: a pilot study. J Med Liban 2002; 50: 23-25. 9.
• Tan YH, Tan KY, Foo KT. The role of a trial of
• antibiotics in asymptomatic patients with elevated
• prostate-specifi c antigen – an Asian perspective. BJU Int 2000; 86: 104.
• Erol H, Beder N, Calişkan T, et al. Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies? Urol Int 2006; 76: 20- 26.
• Dai B, Ye DW, Kong YY, et al. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels. Asian J Androl 2008; 10: 325-331.
• Raaijmakers R, Wildhagen MF, Ito K, et al. Prostate- specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. Urology 2004; 63: 316-320.
• Kaygisiz O, Ugurlu O, Kosan M, et al. Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/mL. Prostate Cancer Prostatic Dis 2006; 9: 235-238.